Dedifferentiated Liposarcoma — Trials

Dedifferentiated Liposarcoma — Trials · CancerIndex

Clinical trials

Registered studies

35 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 19
Recruiting: 9
Ph III recruiting: 1
Growth YoY: —
Industry share: 16%
Top sponsor: Memorial Sloan Kettering Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (5)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05496569	TQB3616 Capsules in the Treatment of Dedifferentiated Liposarcoma	terminated	Phase 2	26	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY	1	Nov 21, 2025	clinicaltrials
NCT05580588	Open-Label Study of the CDK4/6 Inhibitor SPH4336 in Subjects With Locally Advanced or Metastatic Liposarcomas	terminated	Phase 2	14	Shanghai Pharma Biotherapeutics USA Inc.INDUSTRY	1	Jun 13, 2025	clinicaltrials